Table of Contents
Chemotherapy Research and Practice
Volume 2012 (2012), Article ID 905796, 10 pages
http://dx.doi.org/10.1155/2012/905796
Research Article

Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer Micelles

1Department of Pharmaceutical Sciences and Center for Drug Delivery and Nanomedicine, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-5830, USA
2Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, V-234, Moscow 119992, Russia
3Department of Pathology and Microbiology and Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, Omaha, NE 68198-3135, USA

Received 24 February 2012; Revised 10 April 2012; Accepted 26 April 2012

Academic Editor: Vassilios A. Georgoulias

Copyright © 2012 Hardeep S. Oberoi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Go and A. A. Adjei, “Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin,” Journal of Clinical Oncology, vol. 17, no. 1, pp. 409–422, 1999. View at Google Scholar · View at Scopus
  2. M. A. Jakupec, M. Galanski, and B. K. Keppler, “Tumour-inhibiting platinum complexes—state of the art and future perspectives,” Reviews of Physiology, Biochemistry and Pharmacology, vol. 146, pp. 1–54, 2003. View at Google Scholar · View at Scopus
  3. E. Raymond, S. G. Chaney, A. Taamma, and E. Cvitkovic, “Oxaliplatin: a review of preclinical and clinical studies,” Annals of Oncology, vol. 9, no. 10, pp. 1053–1071, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. J. T. Hartmann and H. P. Lipp, “Toxicity of platinum compounds,” Expert Opinion on Pharmacotherapy, vol. 4, no. 6, pp. 889–901, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Grothey, “Oxaliplatin-safety profile: neurotoxicity,” Seminars in Oncology, vol. 30, no. 4, pp. 5–13, 2003. View at Google Scholar · View at Scopus
  6. J. Cassidy and J. L. Misset, “Oxaliplatin-related side effects: characteristics and management,” Seminars in Oncology, vol. 29, no. 5, pp. 11–20, 2002. View at Google Scholar · View at Scopus
  7. J. Labaye, D. Sarret, C. Duvic et al., “Renal toxicity of oxaliplatin,” Nephrology Dialysis Transplantation, vol. 20, pp. 1275–1276, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Pinotti and B. Martinelli, “A case of acute tubular necrosis due to oxaliplatin,” Annals of Oncology, vol. 13, no. 12, pp. 1951–1952, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Ulusakarya, S. Misra, M. Haydar et al., “Acute renal failure related to oxaliplatin-induced intravascular hemolysis,” Medical Oncology, vol. 27, no. 4, pp. 1425–1426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kawazoe, H. Kawazoe, H. Sugishita et al., “Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment,” Gan To Kagaku Ryoho, vol. 37, no. 6, pp. 1153–1157, 2010. View at Google Scholar · View at Scopus
  11. M. A. Graham, G. F. Lockwood, D. Greenslade, S. Brienza, M. Bayssas, and E. Gamelin, “Clinical pharmacokinetics of oxaliplatin: a critical review,” Clinical Cancer Research, vol. 6, no. 4, pp. 1205–1218, 2000. View at Google Scholar · View at Scopus
  12. F. Grolleau, L. Gamelin, M. Boisdron-Celle, B. Lapied, M. Pelhate, and E. Gamelin, “A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels,” Journal of Neurophysiology, vol. 85, no. 5, pp. 2293–2297, 2001. View at Google Scholar · View at Scopus
  13. H. Cabral, N. Nishiyama, S. Okazaki, H. Koyama, and K. Kataoka, “Preparation and biological properties of dichloro(1,2-diaminocyclohexane) platinum(II) (DACHPt)-loaded polymeric micelles,” Journal of Controlled Release, vol. 101, no. 1–3, pp. 223–232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Cabral, N. Nishiyama, and K. Kataoka, “Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity,” Journal of Controlled Release, vol. 121, no. 3, pp. 146–155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. P. Nowotnik and E. Cvitkovic, “ProLindac (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic,” Advanced Drug Delivery Reviews, vol. 61, no. 13, pp. 1214–1219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. S. Oberoi, N. V. Nukolova, F. C. Laquer et al., “Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, anti-tumor activity and toxicity in mice,” International Journal of Nanomedicine, no. 7, pp. 2557–2571, 2012. View at Google Scholar
  17. S. Bontha, A. V. Kabanov, and T. K. Bronich, “Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs,” Journal of Controlled Release, vol. 114, no. 2, pp. 163–174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. K. Bronich, P. A. Keifer, L. S. Shlyakhtenko, and A. V. Kabanov, “Polymer micelle with cross-linked ionic core,” Journal of the American Chemical Society, vol. 127, no. 23, pp. 8236–8237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Google Scholar · View at Scopus
  20. U. Roy, J. McMillan, Y. Alnouti et al., “Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human PBL-reconstituted mice,” Journal of Infectious Diseases. In press.
  21. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, “Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review,” Journal of Controlled Release, vol. 65, no. 1-2, pp. 271–284, 2000. View at Publisher · View at Google Scholar
  22. J. O. Kim, N. V. Nukolova, H. S. Oberoi, A. V. Kabanov, and T. K. Bronich, “Block ionomer complex micelles with cross-linked cores for drug delivery,” Polymer Science, vol. 51, no. 6, pp. 708–718, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Sahay, J. O. Kim, A. V. Kabanov, and T. K. Bronich, “The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents,” Biomaterials, vol. 31, no. 5, pp. 923–933, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Hall, M. Okabe, D. W. Shen, X. J. Liang, and M. M. Gottesman, “The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy,” Annual Review of Pharmacology and Toxicology, vol. 48, pp. 495–535, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. S. Oberoi, F. C. Laquer, L. A. Marky, A. V. Kabanov, and T. K. Bronich, “Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum(II),” Journal of Controlled Release, vol. 153, no. 1, pp. 64–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Magzoub, A. Pramanik, and A. Gräslund, “Modeling the endosomal escape of cell-penetrating peptides: transmembrane pH gradient driven translocation across phospholipid bilayers,” Biochemistry, vol. 44, no. 45, pp. 14890–14897, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Endoh and T. Ohtsuki, “Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape,” Advanced Drug Delivery Reviews, vol. 61, no. 9, pp. 704–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. D. Perrone, N. E. Madias, and A. S. Levey, “Serum creatinine as an index of renal function: new insights into old concepts,” Clinical Chemistry, vol. 38, no. 10, pp. 1933–1953, 1992. View at Google Scholar · View at Scopus